青蒿素减轻LPS诱导的肠上皮细胞屏障功能损伤的实验研究

目的:探究青蒿素对脂多糖(lipopolysaccharide,LPS)诱导的大鼠肠上皮IEC-6细胞屏障功能损伤的影响。方法:体外培养IEC-6细胞,随机分为5组:对照组、LPS(100 mg/L)组和LPS+青蒿素(30、50和100μmol/L)组,MTT法检测各组细胞毒性变化,ELISA检测各组细胞分泌炎性因子TNF-α、IL-1β和IL-6水平的变化,电阻仪检测肠上皮细胞跨上皮电阻(TER),酶标仪检测单层细胞对辣根过氧化物酶(HRP)的通透性,RT-qPCR和Western blot检测各组细胞紧密连接蛋白(ZO-1、claudin-1和occludin)以及TLR4/My D88/NF-κB mRNA和蛋白表达的变化。结果:LPS与青蒿素在本实验浓度范围对IEC-6细胞均无毒性。与对照组相比,LPS处理下,细胞分泌TNF-α、IL-1β和IL-6水平以及TLR4/My D88/NF-κB的mRNA和蛋白表达明显增加,ZO-1、claudin-1和occludin的mRNA和蛋白表达降低。而青蒿素干预下,细胞分泌TNF-α、IL-1β和IL-6水平以及TLR4/My D88/NF-κB mRNA和蛋白表达明显降低,ZO-1、claudin-1和occludin的mRNA和蛋白表达升高(P0.05),均呈现浓度依赖性。结论:青蒿素可能通过抑制TLR4/My D88/NF-κB通路减轻LPS诱导的肠上皮细胞屏障功能损伤。

Artemisinin attenuates intestinal epithelial barrier damage induced by LPS

AIM: To investigate the effect of artemisinin on lipopolysaccharide(LPS)-induced intestinal epithelial barrier damage in IEC-6 cells and its molecular mechanism. METHODS: Cultured IEC-6 cells were divided to 5 groups: control group, LPS(100 mg/L) group and LPS+Artemisinin(30, 50 and 100 μmol/L) groups. The cytotoxicity was detected by MTT assay. The releases of TNF-α, IL-1β and IL-6 in the IEC-6 cells were measured by ELISA. The transepithelial electrical resistance(TER) was detected by electrical resistance tester, and the horseradish peroxidase(HRP) flux permeability were analyzed by a microplate reader. The expression of tight junction proteins, ZO-1, claudin-1 and occludin, and the expression of TLR4/MyD88/NF-κB at mRNA and protein levels were determined by RT-qPCR and Western blot. RESULTS: Artemisinin alone(up to 100 μmol/L) or in combination with LPS(100 mg/L) was not toxic to IEC-6 cells. Compared with control group, the releases of TNF-α, IL-1β and IL-6 in the culture supernatant of IEC-6 cells significantly increased after treatment with LPS. The expression of TLR4/MyD88/NF-κB was activated by LPS. LPS down-regulated the protein expression of ZO-1, claudin-1 and occludin. However, artemisinin treatment decreased the releases of TNF-α, IL-1β and IL-6 in the culture supernatant of IEC-6 cells. The expression of TLR4/MyD88/NF-κB at mRNA and protein levels was gradually reduced after treatment with artemisinin. In addition, artemisinin upregulated the protein expression of ZO-1, claudin-1 and occludin significantly(P<0.01) in a dose-dependent manner. CONCLUSION: Artemisinin attenuates LPS-induced intestinal epithelial barrier damage by inhibiting TLR4/MyD88/NF-κB activation in the IEC-6 cells.